Covered recipient · General Payments record
WHITNEY TEW
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$100,858.61
- Reported across 746 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $64,721.20 | 26 |
| Food and Beverage | $321.11 | 22 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| CSL Plasma Inc. | $64,721.20 | 26 |
| ABBVIE INC. | $164.32 | 15 |
| Takeda Pharmaceuticals U.S.A., Inc. | $63.77 | 2 |
| Lilly USA, LLC | $31.78 | 2 |
| Amgen Inc. | $24.56 | 1 |
| Novo Nordisk AS | $20.08 | 1 |
| IBSA Pharma Inc. | $16.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (48)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.91 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212758 | CMS |
| ABBVIE INC. | $14.30 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212760 | CMS |
| ABBVIE INC. | $14.37 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212762 | CMS |
| ABBVIE INC. | $4.40 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212764 | CMS |
| ABBVIE INC. | $14.82 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212766 | CMS |
| ABBVIE INC. | $15.25 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212768 | CMS |
| ABBVIE INC. | $11.76 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212770 | CMS |
| ABBVIE INC. | $2.21 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212772 | CMS |
| ABBVIE INC. | $10.53 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212774 | CMS |
| ABBVIE INC. | $15.18 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212776 | CMS |
| ABBVIE INC. | $8.37 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212778 | CMS |
| ABBVIE INC. | $11.54 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212780 | CMS |
| ABBVIE INC. | $1.73 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212782 | CMS |
| ABBVIE INC. | $12.52 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212784 | CMS |
| ABBVIE INC. | $11.43 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106212786 | CMS |
| Amgen Inc. | $24.56 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117699446 | CMS |
| CSL Plasma Inc. | $2,391.20 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660183 | CMS |
| CSL Plasma Inc. | $2,391.20 | 01/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660207 | CMS |
| CSL Plasma Inc. | $2,391.20 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660185 | CMS |
| CSL Plasma Inc. | $2,466.20 | 02/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660187 | CMS |
| CSL Plasma Inc. | $2,691.20 | 02/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660189 | CMS |
| CSL Plasma Inc. | $2,991.20 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660191 | CMS |
| CSL Plasma Inc. | $2,916.20 | 03/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660193 | CMS |
| CSL Plasma Inc. | $2,391.20 | 04/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660195 | CMS |
| CSL Plasma Inc. | $2,391.20 | 04/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660197 | CMS |
| CSL Plasma Inc. | $2,691.20 | 05/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660199 | CMS |
| CSL Plasma Inc. | $2,691.20 | 05/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660201 | CMS |
| CSL Plasma Inc. | $2,841.20 | 06/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660203 | CMS |
| CSL Plasma Inc. | $2,391.20 | 06/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134660205 | CMS |
| CSL Plasma Inc. | $2,391.20 | 07/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142462 | CMS |
| CSL Plasma Inc. | $2,391.20 | 07/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142464 | CMS |
| CSL Plasma Inc. | $2,391.20 | 07/31/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142466 | CMS |
| CSL Plasma Inc. | $2,391.20 | 08/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142468 | CMS |
| CSL Plasma Inc. | $2,391.20 | 08/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142470 | CMS |
| CSL Plasma Inc. | $2,391.20 | 09/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142472 | CMS |
| CSL Plasma Inc. | $2,391.20 | 09/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142474 | CMS |
| CSL Plasma Inc. | $2,391.20 | 10/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142476 | CMS |
| CSL Plasma Inc. | $2,391.20 | 10/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142478 | CMS |
| CSL Plasma Inc. | $2,391.20 | 11/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142480 | CMS |
| CSL Plasma Inc. | $2,391.20 | 11/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142482 | CMS |
| CSL Plasma Inc. | $2,391.20 | 12/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142484 | CMS |
| CSL Plasma Inc. | $2,391.20 | 12/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1142142486 | CMS |
| IBSA Pharma Inc. | $16.60 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142984696 | CMS |
| Lilly USA, LLC | $17.50 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135497264 | CMS |
| Lilly USA, LLC | $14.28 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135481313 | CMS |
| Novo Nordisk Inc | $20.08 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096958782 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.76 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137687046 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.01 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137687048 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.